Latest current cash for IMMP: $69M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), IMMP shows a current cash of $69M. That compares with $67M in the prior-year period — up 2.2% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, IMMP's current cash is now $69M (was $67M) — a 2.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Immutep Limited is outperforming or lagging.
Tracking IMMP's current cash over time shows whether Immutep Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $69M That compares with $67M in the prior-year period — up 2.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Immutep Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $69M) with ownership activity and broader fundamentals.
Immutep Limited's current cash is $69M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.